edema/inflamație

Linkul este salvat în clipboard

Alegeți tipul de sortare

Pagină 1 din 141 rezultate

Electromagnetic method of treatment of lesions associated with inadequate blood perfusion, partial denervation, tissue loss, pain, edema, inflammation and infection

Numai utilizatorii înregistrați pot traduce articole

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates generally to a method for treatment of skin lesions and internal wounds such as viable but underperfused myocardium. More specifically, this invention is related to a method for treatment of a subject afflicted with

3,4-Dihydrospiro-2H-1,3-benzoxazines and their use in treating edema, abnormal electrolyte retention, and inflammation

Numai utilizatorii înregistrați pot traduce articole

This invention is concerned with novel 3,4-dihydrospiro-2H-1,3-benzoxazines having therapeutic utility, processes for their preparation, methods of treating inflammation, edema and autoimmune diseases, and novel pharmaceutical formulations comprising at least one of the novel compounds as active

Method for treating an inflammatory brain disease comprising administering a stem cell-derived exosome

Numai utilizatorii înregistrați pot traduce articole

CROSS-REFERENCE TO RELATED APPLICATIONS This application is a national phase application of PCT Application No. PCT/KR2015/002640, filed on Mar. 18, 2015, which claims the benefit and priority to Korean Patent Application No. 10-2014-0031624, filed Mar. 18, 2014. The entire disclosures of the

Composition for treating inflammatory brain diseases which includes stem cell as active ingredient

Numai utilizatorii înregistrați pot traduce articole

TECHNICAL FIELD The present invention relates to a composition for treating inflammatory brain diseases, comprising stem cells as an active ingredient. BACKGROUND ART Stem cells refer to cells having the ability to self-replicate and the ability to differentiate into at least two cells and can be

Prophylactic and therapeutic methods for treating edema with antamanides

Numai utilizatorii înregistrați pot traduce articole

GOVERNMENTAL SUPPORT Research support for the present invention was provided by U.S. Public Health Service NHLB Grants Numbers HL16714 and HL33104. FIELD OF THE INVENTION The present invention is concerned with inflammatory and non-inflammatory associated edemas and is particularly directed to

Prophylactic and therapeutic methods for treating interleukin-mediated edemas

Numai utilizatorii înregistrați pot traduce articole

FIELD OF THE INVENTION The present invention is concerned with inflammatory and non-inflammatory (hydraulic) associated edemas and is particularly directed to prophylactic and therapeutic methods for treating localized and systemic edemas caused or mediated by interleukins. BACKGROUND OF THE

Method of inhibiting inflammatory response

Numai utilizatorii înregistrați pot traduce articole

FIELD OF THE INVENTION This invention generally relates to a method of inhibiting an inflammatory response of skin or mucosal membranes to injury, and more particularly to the use certain neuropeptides, particularly of Corticotropin Releasing Factor and its analogs, in attenuating inflammation of

Pharmaceutical composition for preventing or treating inflammatory diseases comprising trachelospermi caulis extract and paeonia suffruticosa andrews extract, and method for preparing the same

Numai utilizatorii înregistrați pot traduce articole

CROSS-REFERENCES TO RELATED APPLICATIONS This application is a U.S. national phase application of International PCT Patent Application No. PCT/KR2011/006094, which was filed on Aug. 18, 2011, which claims priority to Korean Patent Application Nos. 10-2010-0123086, filed Dec. 3, 2010;

2,3-di-substituted-5,6-dihydroimidazo [2,1-b] thiazole, its salts, production thereof and anti-inflammatory agent containing the same

Numai utilizatorii înregistrați pot traduce articole

This invention relates to novel imidazothiazole derivatives, their salts, a method for the production thereof, and anti-inflammatory compositions containing the same. More particularly, this invention relates to 2,3-di-substituted-5,6-dihydroimidazo [2,1-b] thiazole, its salts, a method for the

2,-3-Di-substituted-5,6-dihydroimidazo [2,1-b] thiazole, its salts, production thereof and anti-inflammatory agent containing the same

Numai utilizatorii înregistrați pot traduce articole

Triazine derivatives to treat pain, fever, inflammation, allergies and thrombosis

Numai utilizatorii înregistrați pot traduce articole

N-nicotinoylhalogenobenzoguanamines are known in the art to exhibit strong anti-inflammatory action (see Japanese patent application No. 56-87124). It has now been discovered that triazine derivatives of the formula (I): ##STR2## and pharmaceutically acceptable salts thereof wherein R.sup.1 and

Method for treating inflammation, arthritis or disc diseases using a mixed extract of cibotii rhizoma, ledebouriellae radix, achyranthis radix, paeonia lactiflora pall and glycyrrhizae radix

Numai utilizatorii înregistrați pot traduce articole

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a method for treating inflammatory or degenerative diseases by administering to an individual a pharmaceutically effective amount of a mixed extract of Cibotii Rhizoma, Ledebouriellae Radix, Achyranthis Radix,

Plasminogen activator as an anti-inflammatory agent

Numai utilizatorii înregistrați pot traduce articole

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to the use of plasminogen activator as an anti-inflammatory agent. 2. Description of the Related Art Plasminogen activators play an important physiological role in the regulation of thrombolysis. This action is

Inhibitors of placental growth factor for the treatment of pathological angiogenesis, pathological arteriogenesis, inflammation, tumor formation and/or vascular leakage

Numai utilizatorii înregistrați pot traduce articole

FIELD OF THE INVENTION The invention relates to the field of pathological angiogenesis and arteriogenesis. In particular, the invention describes a stress-induced phenotype in a transgenic mouse (PIGF-) that does not produce Placental Growth Factor (PIGF) and that demonstrates an impaired vascular

LIF for use in modulating inflammation and pain

Numai utilizatorii înregistrați pot traduce articole

FIELD OF THE INVENTION This invention is related to the use of leukemia inhibitory factor (LIF) and other agonists of the LIF receptor, in the regulation of inflammation and pain. BACKGROUND Leukemia inhibitory factor (LIF) belongs to the neuropoietic cytokine family, which also includes ciliary

Anterior
1
2
3
4
5
6
...
9
10
Următor →

Alăturați-vă paginii
noastre de facebook

Herbal & Natural Medicine

Cea mai completă bază de date cu plante medicinale susținută de știință

Funcționează în 55 de limbi
Cure pe bază de plante susținute de știință
Recunoașterea ierburilor după imagine
Harta GPS interactivă - etichetați ierburile în locație (în curând)
Citiți publicațiile științifice legate de căutarea dvs.
Căutați plante medicinale după efectele lor
Organizați-vă interesele și rămâneți la curent cu noutățile de cercetare, studiile clinice și brevetele

Tastați un simptom sau o boală și citiți despre plante care ar putea ajuta, tastați o plantă și vedeți boli și simptome împotriva cărora este folosit.
* Toate informațiile se bazează pe cercetări științifice publicate